poisar

Stock

Sanofi ADS SNY

$44.85-1.31%

Overview

SNY market data

Price History

SNY price chart · 1M
O
44.85
H
45.08
L
44.74
C
44.85
Vol
135,418.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$44.85
Previous Close
$45.44
Day High
$45.08
Day Low
$44.74
52 Week High
$46.11
52 Week Low
$40.90
7 Day Return
-0.61%
30 Day Return
-1.50%
90 Day Return
+2.64%
1 Year Return
+1.28%
Daily Notional Volume
$6.1M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
16.24
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$6.37
Diluted earnings per share over the trailing twelve months.
Beta
0.77
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
4.1%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
9.3%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$71.25 – $91.15
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $90.5B · P/B 1.41 · P/S 1.50.

Company News

10 captured
$7+ Billion mRNA Vaccines Market Outlook, 2035: Opportunities, Strategies, ChallengesGlobenewswire Inc · Aug 26, 2026, 2:15 PM
AI Poised to Reshape Blood Cancer Therapeutics as Investment Surges Past $2 Billion Across Leading Biotech and Pharma PlayersGlobenewswire Inc · Aug 25, 2026, 5:15 PM
Dr. Oz Says The MMR Vaccine Is Not 'Lethal' as Trump Administration Faces Questions Over Vaccine PolicyBenzinga · Aug 24, 2026, 1:28 PM
European Medicines Agency Concerns Prompt Sanofi To Pull Dupixent IndicationBenzinga · Aug 18, 2026, 2:46 PM
EU EMA Announces Sanofi Winthrop Industrie Withdrew Its Application For The Use Of Dupixent In The Treatment Of Adults With Moderate-To-Severe Bullous Pemphigoid On June 24Benzinga · Aug 18, 2026, 11:18 AM
Trump Cuts Core Childhood Vaccine Recommendations to 11, Bill Cassidy Says 'This Executive Order Is Wrong' (UPDATED)Benzinga · Aug 11, 2026, 3:01 AM
Trump Says Administration Recognizing Childhood Vaccine Recommendations For Only 11 Core Vaccinations; Hepatitis B, COVID-19, Influenza No Longer Recommended For All ChildrenBenzinga · Aug 10, 2026, 7:00 PM
Global Influenza Vaccine Market Report, 2026 Edition - Profiles GlaxoSmithKline, Pfizer, Sanofi, Moderna, and 9 Other PlayersGlobenewswire Inc · Aug 7, 2026, 11:00 AM
Nurix Therapeutics Earns $10M Milestone Payment Following Initiation Of Sanofi's Phase 1 Clinical Study Of SAR448272/NX-3911Benzinga · Aug 4, 2026, 11:14 AM
Sanofi Secures EU Approval For MenQuadfi In Infants From Six Weeks, Backed By Immunogenicity Data From Pivotal MET58 StudyBenzinga · Aug 4, 2026, 5:20 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock